Literature DB >> 29764958

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.

Charlotte Jackson1, Jo Southern2, Ajit Lalvani3, Francis Drobniewski3,4, Chris J Griffiths5, Marc Lipman6,7, Graham H Bothamley8, Jonathan J Deeks9,10, Ambreen Imran2, Onn Min Kon11,12, Sithembinkosi Mpofu2, Vladyslav Nikolayevskyy3,4,13, Melanie Rees-Roberts3, Alice Sitch9, Saranya Sridhar3, Chuen-Yan Tsou4, Hilary Whitworth3,14, Ibrahim Abubakar1.   

Abstract

We conducted a cross-sectional analysis of baseline data from a UK cohort study which enrolled participants at risk of latent tuberculosis infection (LTBI, defined as a positive result for either of the two interferon gamma release assays). Binomial regression with a log link was used to estimate crude and adjusted prevalence ratios (PRs) and 95% CIs for the relationship between diabetes mellitus (DM) and LTBI. Adjusted for age, sex, ethnicity, body mass index and the presence of other immunocompromising conditions, DM was associated with a 15% higher prevalence of LTBI (adjusted PR=1.15, 95% CI 1.02 to 1.30, p=0.025). TRIAL REGISTRATION NUMBER: PREDICT is registered on clinicaltrials.gov (NCT01162265). © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  clinical epidemiology; tuberculosis

Mesh:

Year:  2018        PMID: 29764958     DOI: 10.1136/thoraxjnl-2017-211124

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Progress in interferon-gamma release assay development and applications: an unfolding story of translational research.

Authors:  Ajit Lalvani; Hilary S Whitworth
Journal:  Ann Transl Med       Date:  2019-07

2.  The Association Between Diabetes Mellitus and the Risk of Latent Tuberculosis Infection: A Systematic Review and Meta-Analysis.

Authors:  Qiao Liu; Wenxin Yan; Runqing Liu; Ershu Bo; Jue Liu; Min Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-25

3.  Tuberculosis Infection Among People With Diabetes: United States Population Differences by Race/Ethnicity.

Authors:  Maryam B Haddad; Timothy L Lash; Kenneth G Castro; Andrew N Hill; Thomas R Navin; Neel R Gandhi; Matthew J Magee
Journal:  Am J Prev Med       Date:  2020-02-13       Impact factor: 5.043

Review 4.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

5.  BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells.

Authors:  Harindra D Sathkumara; Saparna Pai; Michel de Jesús Aceves-Sánchez; Natkunam Ketheesan; Mario Alberto Flores-Valdez; Andreas Kupz
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

Review 6.  Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population.

Authors:  Ying Yang; Hong-Jiao Wang; Wei-Lin Hu; Guan-Nan Bai; Chun-Zhen Hua
Journal:  Diagnostics (Basel)       Date:  2022-02-10

7.  Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection.

Authors:  A Largen; A Ayala; R Khurana; D J Katz; T K Venkatappa; R Brostrom
Journal:  Int J Tuberc Lung Dis       Date:  2021-07-01       Impact factor: 3.427

8.  Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia.

Authors:  Emad Ali Al Khoufi
Journal:  Pan Afr Med J       Date:  2021-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.